Recommended across the site

The availability of pancreatic enzyme replacement therapies (PERTs) varies currently. Use our resources and mini-tool to find matches for licensed products.
Modified-release methylphenidate capsules and tablets differ. Ensure patients receive appropriate treatment, particularly during periods of supply disruption.
The availability of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD) varies currently. Supply content is maintained regularly by DHSC.
This guidance explores the dosing and monitoring advice when using high dose loperamide to reduce high stoma output or in short bowel syndrome in adults.
We outline key clinical considerations when initiating statins in patients with liver disease or liver impairment.
Treatment of adrenal crisis is time critical and relies on timely use of injectable hydrocortisone to prevent harm.
We announce the start of a national scoping review on the safer use of time critical medicines and further resources coming soon.

Planning

Regularly updated material to support the introduction of adalimumab, eculizumab, natalizumab, ranibizumab, tocilizumab and ustekinumab biosimilars.
Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.

Events

Personalising evidence-based medicine to reduce polypharmacy

An insight on principles of patient centred structured medication reviews; using the current evidence and shared decision making to facilitate de-prescribing.

Personalised evidence-based medicine to minimise polypharmacy

A consultant pharmacist will use case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.

Deviation capture and trending in pharmacy technical services

An SPS Quality Assurance (QA) bite size learning event on deviation capture and trending of data in pharmacy technical services.

Tools

Latest information on supply issues, actions to take, alternatives to use, and expected resolution dates. Content provided by DHSC and MVA team, NHS England.
Summarised recommendations and guidance for medicines requiring monitoring to save you time when you're making monitoring decisions with patients
Information on stability for tablets and capsules to help create MCAs for patients. Find entries and then build and print lists specific to your MCA.
Advice on whether refrigerated medicines can or can’t be used after exposure to out-of-range temperatures. Find entries and build and print lists.
Information on drug stability to help users make an informed decision on the shelf life for products prepared within aseptic facilities.
View how your organisation is performing for a number of key molecules and compare your performance with others.

Recommended in PGDs

Delegation of any PGD function is not permitted. However there are specific tasks that individuals other than the professional working under a PGD can fulfil.
Understand what a Patient Group Direction (PGD) is and how it is used in clinical practice.
Understanding when PGDs are a suitable mechanism for the supply and/or administration of medicines ensures an appropriate legal framework for service provision.
Understanding when PGDs are an unsuitable mechanism for the supply and/or administration of medicines ensures an alternative legal framework is applied.
Understanding where PGDs can and cannot be used for the supply and/or administration of P and GSL medicines helps ensure correct legal mechanisms in practice.
National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.

Primary care

Our primary care resources and tools are for all those working in the area, including GPs, practice pharmacists and community pharmacy teams.

If you're a healthcare professional who needs further advice, get in touch with us. You can contact us through our single email or telephone number below. Please don't share patient identifiable data with us by email.
All our advice on using medicines safely and effectively in patients with swallowing difficulties.
All our training and guidance to help decision making about the use of medicines in breastfeeding.
All our training and guidance to help decision making about the use of medicines in pregnancy.
Medication Safety Across the System (MSATS) provides resources and networking to inspire and equip individuals in promoting the safe use of medicines.
Practical guidance on effective collaboration opportunities to promote medication safety improvements
Effective communication allows for timely responses to new and emerging medication risks and the sharing of potential safety solutions.
Healthcare professionals responsible for medication safety in their organisation must deliver an appropriate response to safety alerts
High quality reporting and management of incidents and harms ensures opportunities for learning and improving medication safety
Practical guidance to ensure opportunities to learn from local intelligence, including patient harm are translated into shared local and national learning
Healthcare professionals delivering the medication safety agenda in their organisation require an understanding of national policy, frameworks and legislation
Effective use provides assurance that an organisation is aware of the most critical medication safety related information, and acts on this to improve safety
Increased medication incident reporting provides greater opportunities for learning and improving medication safety
Practical guidance to support those undertaking medication incident investigations
admin